Blog
_0.png?locale=de){kind=logo}
How Will FDA Approval of COVID Vaccines in Younger Kids Impact Pfizer?
Children ages 5 through 11 will now be able to receive the COVID-19 vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX). In this Motley Fool Live video recorded on Oct. 27, 2021
3 Stocks to Watch This Earnings Season
We're a few weeks into third quarter earnings season, but many companies still haven't released their latest results. In this Fool Live video clip, recorded on Oct. 18, Fool.com contributor Matt
Alignment Healthcare Inc (ALHC) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool.
Alignment Healthcare Inc (NASDAQ: ALHC)Q3 2021 Earnings CallNov 4, 2021, 5:30 p.m. ET
Operator
Source Fool.com
Is It Too Late to Buy Pfizer Stock?
Pfizer (NYSE: PFE) has become an expert at firsts. The pharmaceutical giant became the first to launch a coronavirus vaccine last year. Since then, it's scored a bunch more: bringing a COVID-19
From $47 Billion to $9 Billion: Is WeWork a Buy Now?
Once a flashy media darling, office-sharing company WeWork (NYSE: WE) quickly faded into the background after a failed 2019 initial public offering (IPO) and the departure of its charismatic
3 COVID Pill Stocks That Might Be Game-Changers
Despite the tremendous success of vaccines against the coronavirus, there's always more work to be done when it comes to reducing the risks associated with infection. And if the billions of dollars
Here's How Marijuana Stocks Have Performed After Replacing Their CEOs
Last month, cannabis producer Hexo (NASDAQ: HEXO) made news when it announced a change in leadership. It's not an uncommon occurrence in a fast-changing industry like marijuana where companies are
It's Getting Harder to Qualify for Social Security Benefits -- Here's Why
It's easy to think of Social Security as an entitlement program, but in reality, seniors who qualify for benefits do so by earning enough money in their lifetime and paying taxes on those earnings
Why Boosters Approval in Europe Is a Big Deal for Moderna
The European Medicines Agency's Committee for Medicinal Products for Human Use recently recommended a booster dose for Moderna's (NASDAQ: MRNA) COVID-19 vaccine for individuals ages 18 and up. In
13,447 Reasons to Avoid Shiba Inu Like the Plague
There are a lot of ways for investors to make money. They can buy bonds, put their money to work in bank certificates of deposit, purchase a commodity like oil or gold, or buy property/housing. But
Is Ocugen's Surge Much Ado About Nothing?
Ocugen (NASDAQ: OCGN) stock enjoyed a big run-up as investors awaited a decision by the World Health Organization (WHO) on Emergency Use Listing (EUL) for COVID-19 vaccine Covaxin. In this Motley
Carvana Co (CVNA) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool.
Carvana Co (NYSE: CVNA)Q3 2021 Earnings CallNov 4, 2021, 5:30 p.m. ET
Operator
Source Fool.com
3 Reasons Why Investors Should Love Regeneron's Q3 Update
Regeneron Pharmaceuticals (NASDAQ: REGN) announced its third-quarter earnings before the market opened on Thursday. Based on the stock's move, you might think that those results weren't very good
Great Ajax Corp (AJX) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool.
Great Ajax Corp (NYSE: AJX)Q3 2021 Earnings CallNov 4, 2021, 5:00 p.m. ET
Operator
Source Fool.com
Can Vertex Make Billions With a New Game-Changing Treatment? The Answer May Be Just Ahead
Vertex Pharmaceuticals (NASDAQ: VRTX) brings in billions of dollars in annual profit and revenue from its four cystic fibrosis (CF) treatments. The company is doing so well that, during this week's
The Only 3 Things in Moderna's Q3 Update That Really Matter
Moderna (NASDAQ: MRNA) blew it with its third-quarter earnings update on nearly every front. The company reported revenue of $5 billion, far below the consensus Wall Street estimate of $6.2 billion
3 Explosive Stocks to Buy Right Now Without Any Hesitation
You've no doubt heard of FOMO -- the fear of missing out. However, I think there's an even greater fear many investors have that doesn't have an acronym: the fear of losing money. This fear has
It's Time to Buy Novavax After the Biotech's Q3 Update
Novavax (NASDAQ: NVAX) has given plenty of reasons for skeptics to doubt whether or not it would be successful. You can go back to the company's multiple flops in clinical trials of its experimental
3 Stocks to Help You Pick Up the Pieces After Shiba Inu Implodes
Shiba Inu (CRYPTO: SHIB) is likely headed for a colossal collapse. You know it's probably going to happen. I know it's probably going to happen. Elon Musk knows it's probably going to happen.
Recent
The Smartest Ultra-High-Yield Dividend Stocks to Buy With $100 Right Now
Whether or not investors realize it, they've been witnessing history for the past 20 months. First, they watched the benchmark S&P 500 navigate its way to the fastest decline of at least 30% in its
One Number That Will Make You Rethink Your Retirement Savings Goals
When you set your retirement goals, you must make some key assumptions about your future so you can determine how much you'll need invested.
Unfortunately, the majority of Americans are probably
iHeartMedia, inc (IHRT) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool.
iHeartMedia, inc (NASDAQ: IHRT)Q3 2021 Earnings CallNov 4, 2021, 4:30 p.m. ET
Operator
Source Fool.com
3 Ways to Score an Even Bigger Social Security Check
Social Security is the most important source of income for most retirees, but not everyone gets the same size check each month. Several factors determine your benefit amount, but understanding the
Here's How Many People Are Maxing Out Their 401(k)s
Social Security often falls short in helping retirees cover all of their bills because those benefits will usually only replace about 40% of an average earner's pre-retirement wages. Most seniors
BLOOM ENERGY CORP (BE) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool.
BLOOM ENERGY CORP (NYSE: BE)Q3 2021 Earnings CallNov 4, 2021, 5:00 p.m. ET
Ed Vallejo -- Investor Relations
Source Fool.com